244 related articles for article (PubMed ID: 20585865)
1. Para-aortic lymphadenectomy in the management of preoperative grade 1 endometrial cancer confined to the uterine corpus.
Yoon JH; Yoo SC; Kim WY; Chang SJ; Chang KH; Ryu HS
Ann Surg Oncol; 2010 Dec; 17(12):3234-40. PubMed ID: 20585865
[TBL] [Abstract][Full Text] [Related]
2. Lymph-vascular space invasion as a significant risk factor for isolated para-aortic lymph node metastasis in endometrial cancer: a study of 203 consecutive patients.
Chang SJ; Kong TW; Kim WY; Yoo SC; Yoon JH; Chang KH; Ryu HS
Ann Surg Oncol; 2011 Jan; 18(1):58-64. PubMed ID: 20607418
[TBL] [Abstract][Full Text] [Related]
3. Surgical staging for patients presenting with grade 1 endometrial carcinoma.
Ben-Shachar I; Pavelka J; Cohn DE; Copeland LJ; Ramirez N; Manolitsas T; Fowler JM
Obstet Gynecol; 2005 Mar; 105(3):487-93. PubMed ID: 15738013
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of para-aortic lymphadenectomy in early-stage endometrioid uterine corpus cancer.
Tong SY; Lee JM; Lee JK; Kim JW; Cho CH; Kim SM; Park SY; Park CY; Kim KT
Ann Surg Oncol; 2011 May; 18(5):1425-30. PubMed ID: 21136177
[TBL] [Abstract][Full Text] [Related]
5. Retrospective analysis of selective lymphadenectomy in apparent early-stage endometrial cancer.
Cragun JM; Havrilesky LJ; Calingaert B; Synan I; Secord AA; Soper JT; Clarke-Pearson DL; Berchuck A
J Clin Oncol; 2005 Jun; 23(16):3668-75. PubMed ID: 15738538
[TBL] [Abstract][Full Text] [Related]
6. The risk of lymph node metastasis based on myometrial invasion and tumor grade in endometrioid uterine cancers: a multicenter, retrospective Korean study.
Lee KB; Ki KD; Lee JM; Lee JK; Kim JW; Cho CH; Kim SM; Park SY; Jeong DH; Kim KT
Ann Surg Oncol; 2009 Oct; 16(10):2882-7. PubMed ID: 19484311
[TBL] [Abstract][Full Text] [Related]
7. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.
Watari H; Todo Y; Takeda M; Ebina Y; Yamamoto R; Sakuragi N
Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407
[TBL] [Abstract][Full Text] [Related]
8. Potential benefit of lymphadenectomy for the treatment of node-negative locally advanced uterine cancers.
Seago DP; Raman A; Lele S
Gynecol Oncol; 2001 Nov; 83(2):282-5. PubMed ID: 11606085
[TBL] [Abstract][Full Text] [Related]
9. Use of the sentinel node procedure to stage endometrial cancer.
Ballester M; Dubernard G; Rouzier R; Barranger E; Darai E
Ann Surg Oncol; 2008 May; 15(5):1523-9. PubMed ID: 18322758
[TBL] [Abstract][Full Text] [Related]
10. Lymph node spread in stage III or IV primary peritoneal serous papillary carcinoma.
Dubernard G; Morice P; Rey A; Camatte S; Pautier P; Lhommé C; Duvillard P; Castaigne D
Gynecol Oncol; 2005 Apr; 97(1):136-41. PubMed ID: 15790449
[TBL] [Abstract][Full Text] [Related]
11. Optimal surgical debulking in uterine papillary serous carcinoma affects survival.
Patsavas K; Woessner J; Gielda B; Rotmensch J; Yordan E; Bitterman P; Guirguis A
Gynecol Oncol; 2011 Jun; 121(3):581-5. PubMed ID: 21440290
[TBL] [Abstract][Full Text] [Related]
12. Systematic para-aortic and pelvic lymphadenectomy in early stage epithelial ovarian cancer: a prospective study.
Ditto A; Martinelli F; Reato C; Kusamura S; Solima E; Fontanelli R; Haeusler E; Raspagliesi F
Ann Surg Oncol; 2012 Nov; 19(12):3849-55. PubMed ID: 22707110
[TBL] [Abstract][Full Text] [Related]
13. Survival impact of lymphadenectomy stratified by nodal metastatic probability in endometrial cancer.
Koskas M; Fournier M; Luton D; Darai E; Rouzier R
Ann Surg Oncol; 2014 Jul; 21(7):2376-82. PubMed ID: 24590435
[TBL] [Abstract][Full Text] [Related]
14. A validation study of a scoring system to estimate the risk of lymph node metastasis for patients with endometrial cancer for tailoring the indication of lymphadenectomy.
Todo Y; Okamoto K; Hayashi M; Minobe S; Nomura E; Hareyama H; Takeda M; Ebina Y; Watari H; Sakuragi N
Gynecol Oncol; 2007 Mar; 104(3):623-8. PubMed ID: 17097721
[TBL] [Abstract][Full Text] [Related]
15. Systematic pelvic and aortic lymphadenectomy in intermediate and high-risk endometrial cancer: lymph-node mapping and identification of predictive factors for lymph-node status.
Fotopoulou C; Savvatis K; Kraetschell R; Schefold JC; Lichtenegger W; Sehouli J
Eur J Obstet Gynecol Reprod Biol; 2010 Apr; 149(2):199-203. PubMed ID: 20096987
[TBL] [Abstract][Full Text] [Related]
16. Survival advantage of lymphadenectomy in endometrial cancer.
Eggemann H; Ignatov T; Kaiser K; Burger E; Costa SD; Ignatov A
J Cancer Res Clin Oncol; 2016 May; 142(5):1051-60. PubMed ID: 26746654
[TBL] [Abstract][Full Text] [Related]
17. Intraperitoneal radioactive phosphorus (32P) and vaginal brachytherapy as adjuvant treatment for uterine papillary serous carcinoma and clear cell carcinoma: a phase II Hoosier Oncology Group (HOG 97-01) study.
Fakiris AJ; Moore DH; Reddy SR; Look KY; Yiannoutsos CT; Randall ME; Cardenes HR;
Gynecol Oncol; 2005 Mar; 96(3):818-23. PubMed ID: 15721431
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of systematic lymphadenectomy and adjuvant radiotherapy in node-positive endometrial cancer patients.
Mariani A; Dowdy SC; Cliby WA; Haddock MG; Keeney GL; Lesnick TG; Podratz KC
Gynecol Oncol; 2006 May; 101(2):200-8. PubMed ID: 16510174
[TBL] [Abstract][Full Text] [Related]
19. [Lymphadenectomy for uterine cancer].
Gouy S; Uzan C; Zafrani Y; Lhommé C; Pautier P; Duvillard P; Haie-Meder C; Morice P
J Chir (Paris); 2008 Dec; 145 Spec no. 4():12S51-12S55. PubMed ID: 19194359
[TBL] [Abstract][Full Text] [Related]
20. FIGO stage IIIC endometrial carcinoma with metastases confined to pelvic lymph nodes: analysis of treatment outcomes, prognostic variables, and failure patterns following adjuvant radiation therapy.
Nelson G; Randall M; Sutton G; Moore D; Hurteau J; Look K
Gynecol Oncol; 1999 Nov; 75(2):211-4. PubMed ID: 10525373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
